Basics Keros Therapeutics, Inc. IPO Date: April 8, 2020 Sector: Healthcare Industry: Biotech Market Cap: $578.77M Activated in VL: True Average Daily Range Avg Daily Range: $1.20 | 2.71% Avg Daily Range (30 D): $0.17 | 1.24% Avg Daily Range (90 D): $0.23 | 1.78% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .45M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 59 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 1,885 Avg Inst. Trade: $1.89M Avg Inst. Trade (30 D): $1.43M Avg Inst. Trade (90 D): $1.59M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $1.2M Avg Closing Trade (90 D): $1.47M Avg Closing Volume: 53.63K     News May 27, 2025 @ 5:45 PM Leading Independent Proxy Advisory Firm Glass Lewi... Source: Keros Therapeutics, Inc. May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Apr 11, 2025 @ 6:35 PM Deal Dispatch: Harley-Davidson To Wipe Out? Plus, ... Source: Anthony Noto Apr 10, 2025 @ 5:51 PM Keros Therapeutics Goes Up For Sale On Heels Of St... Source: Vandana Singh Feb 28, 2025 @ 10:00 PM Keros Therapeutics Announces Participation at Upco... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.12 $3.66 $-1.12 Diluted EPS $-.16 $3.62 $-1.12 Revenue $ 214.66M $ 211.19M $ 3.04M Gross Profit $ $ $ Net Income / Loss $ 4.21M $ 148.45M $ -46.03M Operating Income / Loss $ -10.31M $ 152.04M $ -53.25M Cost of Revenue $ $ $ Net Cash Flow $ 278.34M $ 160.61M $ 29.25M PE Ratio